Christopher Upton

Array ( [id] => 5303521 [patent_doc_number] => 20090298173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Method of preparing cell for bone tissue formation and application of cell for bone tissue formation' [patent_app_type] => utility [patent_app_number] => 11/920537 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9827 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298173.pdf [firstpage_image] =>[orig_patent_app_number] => 11920537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253009 [patent_doc_number] => 20120157329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'Method and Device for the in Vitro Analysis for MRNA of Genes Involved in Haematological Neoplasias' [patent_app_type] => utility [patent_app_number] => 12/083824 [patent_app_country] => US [patent_app_date] => 2006-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36219 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157329.pdf [firstpage_image] =>[orig_patent_app_number] => 12083824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759902 [patent_doc_number] => 20080312128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Cellular Biomarker Antioxidant Assay and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/912446 [patent_app_country] => US [patent_app_date] => 2006-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16986 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312128.pdf [firstpage_image] =>[orig_patent_app_number] => 11912446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342774 [patent_doc_number] => 20090181424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'Mammalian Expression Vector Comprising the MCMV Promoter and First Intron of HCMV Major Immediate Early Gene' [patent_app_type] => utility [patent_app_number] => 11/887652 [patent_app_country] => US [patent_app_date] => 2006-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9454 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181424.pdf [firstpage_image] =>[orig_patent_app_number] => 11887652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5674150 [patent_doc_number] => 20060179505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/404745 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27405 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20060179505.pdf [firstpage_image] =>[orig_patent_app_number] => 11404745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5627265 [patent_doc_number] => 20060265770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Transgenic mice containing glutamate receptor (GRIK5) gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/330798 [patent_app_country] => US [patent_app_date] => 2006-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23684 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20060265770.pdf [firstpage_image] =>[orig_patent_app_number] => 11330798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7683651 [patent_doc_number] => 20100240760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-23 [patent_title] => 'Biomarkers for Efficacy of Aliskiren as a Hypertensive Agent' [patent_app_type] => utility [patent_app_number] => 11/909202 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18160 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20100240760.pdf [firstpage_image] =>[orig_patent_app_number] => 11909202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667063 [patent_doc_number] => 20060172413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/376438 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24295 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172413.pdf [firstpage_image] =>[orig_patent_app_number] => 11376438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694221 [patent_doc_number] => 20060154368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Transgenic mice containing CX2 gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/376589 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20122 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11376589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5762010 [patent_doc_number] => 20060212955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Transgenic mice containing lymphoid-specific GPCR gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/368134 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 29360 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20060212955.pdf [firstpage_image] =>[orig_patent_app_number] => 11368134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5633794 [patent_doc_number] => 20060150265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Transgenic mice containing sulfotransferase gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/366037 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 24476 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20060150265.pdf [firstpage_image] =>[orig_patent_app_number] => 11366037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428570 [patent_doc_number] => 20090087880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'PROCESS AND GENES FOR EXPRESSION AND\nOVEREXPRESSION OF ACTIVE [FeFe] HYDROGENASES' [patent_app_type] => utility [patent_app_number] => 11/573035 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8971 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087880.pdf [firstpage_image] =>[orig_patent_app_number] => 11573035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515800 [patent_doc_number] => 20090216107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Method of Risk Management for Patients Undergoing Natalizumab Treatment' [patent_app_type] => utility [patent_app_number] => 11/885615 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1772 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216107.pdf [firstpage_image] =>[orig_patent_app_number] => 11885615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5630964 [patent_doc_number] => 20060147432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Tolerogenic antigen-presenting cells' [patent_app_type] => utility [patent_app_number] => 11/361647 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9534 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20060147432.pdf [firstpage_image] =>[orig_patent_app_number] => 11361647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879743 [patent_doc_number] => 20080153126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Mutant Aox1 Promoters' [patent_app_type] => utility [patent_app_number] => 11/817005 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24582 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153126.pdf [firstpage_image] =>[orig_patent_app_number] => 11817005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6135215 [patent_doc_number] => 20110008888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Novel Genetic Approaches to Reduce or Inhibit Tumorgenicity of Human Embryonic Stem Cells and Derivatives Following Transplantation' [patent_app_type] => utility [patent_app_number] => 11/884987 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16067 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008888.pdf [firstpage_image] =>[orig_patent_app_number] => 11884987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324200 [patent_doc_number] => 20090062190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Transcriptional Regulation of Cytokines by LITAF and STAT (6)(B)' [patent_app_type] => utility [patent_app_number] => 11/884854 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17878 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062190.pdf [firstpage_image] =>[orig_patent_app_number] => 11884854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5657986 [patent_doc_number] => 20060143722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'OGR1 gene disruptions, compositions and methods relating thereto' [patent_app_type] => utility [patent_app_number] => 11/360239 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25805 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20060143722.pdf [firstpage_image] =>[orig_patent_app_number] => 11360239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480590 [patent_doc_number] => 20090203547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Gene and Cognate Protein Profiles and Methods to Determine Connective Tissue Markers in Normal and Pathologic Conditions' [patent_app_type] => utility [patent_app_number] => 11/884496 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35998 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203547.pdf [firstpage_image] =>[orig_patent_app_number] => 11884496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663152 [patent_doc_number] => 20080254059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby' [patent_app_type] => utility [patent_app_number] => 11/884086 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 12481 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254059.pdf [firstpage_image] =>[orig_patent_app_number] => 11884086 [rel_patent_id] =>[rel_patent_doc_number] =>)